DK1250600T3 - Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet - Google Patents
Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdetInfo
- Publication number
- DK1250600T3 DK1250600T3 DK01909655T DK01909655T DK1250600T3 DK 1250600 T3 DK1250600 T3 DK 1250600T3 DK 01909655 T DK01909655 T DK 01909655T DK 01909655 T DK01909655 T DK 01909655T DK 1250600 T3 DK1250600 T3 DK 1250600T3
- Authority
- DK
- Denmark
- Prior art keywords
- tau
- phospho
- diagnosis
- tauopathies
- determining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00870008 | 2000-01-24 | ||
US17839100P | 2000-01-27 | 2000-01-27 | |
EP00870280 | 2000-11-22 | ||
PCT/EP2001/000560 WO2001055725A2 (en) | 2000-01-24 | 2001-01-18 | Diagnosis of tauopathies determining tau/phospho-tau ratio |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1250600T3 true DK1250600T3 (da) | 2007-02-05 |
Family
ID=27223742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01909655T DK1250600T3 (da) | 2000-01-24 | 2001-01-18 | Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet |
Country Status (13)
Country | Link |
---|---|
US (2) | US6680173B2 (da) |
EP (1) | EP1250600B1 (da) |
JP (1) | JP5247963B2 (da) |
AT (1) | ATE342509T1 (da) |
AU (1) | AU777837B2 (da) |
BR (1) | BR0107851A (da) |
CA (1) | CA2397991C (da) |
CY (1) | CY1107993T1 (da) |
DE (2) | DE1250600T1 (da) |
DK (1) | DK1250600T3 (da) |
ES (1) | ES2274869T3 (da) |
HK (1) | HK1048513B (da) |
WO (1) | WO2001055725A2 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030162230A1 (en) * | 2000-09-27 | 2003-08-28 | Reagan Kevin J. | Method for quantifying phosphokinase activity on proteins |
JP4681175B2 (ja) * | 2001-09-28 | 2011-05-11 | 三菱化学メディエンス株式会社 | 播種性血管内凝固症候群及びその発症前段階を検出する方法 |
ES2352668T3 (es) * | 2002-08-14 | 2011-02-22 | Mitsubishi Chemical Medience Corporation | Anticuerpo específico para una proteína tau del sistema nervioso central. |
EP1606404A4 (en) * | 2003-03-12 | 2006-04-12 | Assay Designs Inc | PHOSPHOKINASETEST |
CA2445420A1 (en) * | 2003-07-29 | 2005-01-29 | Invitrogen Corporation | Kinase and phosphatase assays |
US7727752B2 (en) * | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US7619059B2 (en) * | 2003-07-29 | 2009-11-17 | Life Technologies Corporation | Bimolecular optical probes |
WO2005080986A1 (en) * | 2004-02-18 | 2005-09-01 | University Of Iowa Research Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
JP4730584B2 (ja) | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
WO2007068105A1 (en) * | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
WO2009143380A2 (en) * | 2008-05-21 | 2009-11-26 | Neurotez, Inc. | Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
WO2011045166A1 (en) | 2009-09-24 | 2011-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction |
WO2011109112A2 (en) * | 2010-03-05 | 2011-09-09 | Albert Einstein College Of Medicine Of Yeshiva University | Method of detecting tau protein and tau fragments in serum |
US20130052669A1 (en) * | 2010-04-30 | 2013-02-28 | Amanda G. Paulovich | Compositions and methods for reliably detecting and/or measuring the amount of a modified target protein in a sample |
CA2826286C (en) | 2011-01-31 | 2021-09-21 | Intellect Neurosciences Inc. | Treatment of tauopathies |
WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
GB201111361D0 (en) * | 2011-07-04 | 2011-08-17 | Nordic Bioscience As | Biochemical markers for neurodegenerative conditions |
DK2885010T3 (da) | 2012-08-16 | 2020-02-03 | Ipierian Inc | Fremgangsmåder til behandling med tauopati |
EP2893042B1 (en) * | 2012-09-05 | 2018-02-14 | Emory University | Diagnostic testing in dementia and methods related thereto |
US8980270B2 (en) | 2013-01-18 | 2015-03-17 | Ipierian, Inc. | Methods of treating a tauopathy |
DK3007726T3 (da) | 2013-06-10 | 2020-07-06 | Ipierian Inc | Fremgangsmåder til behandling af en tauopati |
CR20160270A (es) | 2013-12-20 | 2016-09-05 | Hoffmann La Roche | ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN |
JP2017512751A (ja) | 2014-02-14 | 2017-05-25 | アイピエリアン,インコーポレイティド | タウペプチド、抗タウ抗体、およびそれらの使用方法 |
AU2015243926A1 (en) * | 2014-04-08 | 2016-11-24 | The Research Foundation For The State University Of New York | Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system |
AR100978A1 (es) | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
DE102014013571A1 (de) * | 2014-09-18 | 2016-03-24 | Aj Roboscreen Gmbh | Monoklonaler Antikörper gegen humanes TAU-Protein |
WO2016207245A1 (en) | 2015-06-24 | 2016-12-29 | F. Hoffmann-La Roche Ag | Humanized anti-tau(ps422) antibodies and methods of use |
KR102033776B1 (ko) * | 2017-10-31 | 2019-10-17 | 가천대학교 산학협력단 | 타우 단백질의 발현수준을 측정하는 제제를 포함하는 알츠하이머 중증도 진단용 조성물 및 이를 이용한 알츠하이머 중증도의 진단방법 |
MX2020009277A (es) | 2018-03-05 | 2021-01-08 | Janssen Pharmaceutica Nv | Anticuerpos anti-phf-tau y usos de estos. |
JPWO2020105700A1 (ja) * | 2018-11-22 | 2021-10-07 | 富士レビオ株式会社 | 抗体コンジュゲート |
JP2022527087A (ja) * | 2019-03-28 | 2022-05-30 | ハー・ルンドベック・アクチエゼルスカベット | タウオパチーを診断するためのpS396アッセイの使用 |
US11155609B2 (en) | 2019-04-05 | 2021-10-26 | TauC3 Biologies Limited | Anti-TAUC3 antibodies and uses thereof |
MX2021014473A (es) * | 2019-05-31 | 2022-01-06 | Lilly Co Eli | Compuestos y metodos dirigidos a la tau humana. |
JPWO2021157634A1 (da) * | 2020-02-05 | 2021-08-12 | ||
TW202344840A (zh) * | 2022-01-12 | 2023-11-16 | 英商Gt創新公司 | 診斷檢定 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0600951A4 (en) * | 1991-08-01 | 1996-10-30 | Paul H Voorheis | Diagnostic method for alzheimer's disease. |
ATE165866T1 (de) * | 1992-12-14 | 1998-05-15 | Innogenetics Nv | Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung |
JPH06239899A (ja) * | 1993-02-12 | 1994-08-30 | Teijin Ltd | ヒトタウ蛋白に対する抗体、並びに該抗体を利用する体液中のヒトタウ蛋白の測定方法 |
DE69434811T2 (de) * | 1993-12-21 | 2007-03-01 | Innogenetics N.V. | Monoklonale antikörper gegen phf-tau, hybridomen die diese ausscheiden, antigenerkennung durch diesen antikörper und deren verwendungen |
ATE234324T1 (de) * | 1994-07-29 | 2003-03-15 | Innogenetics Nv | Monoklonale antikörper gegen ein epitop einer gewissen unterklasse oder form von phosphoryliertem tau, hybridome die diese sezernieren,antigenerkennung durch diese antikörper und deren verwendung |
WO1997034145A1 (fr) * | 1996-03-13 | 1997-09-18 | Mitsubishi Chemical Corporation | Anticorps a proteine tau antiphosphorylee et procede de detection de la maladie d'alzheimer l'utilisant |
WO1999062548A1 (en) * | 1998-06-01 | 1999-12-09 | Advanced Research And Technology Institute | Methods and compositions for diagnosing tauopathies |
-
2001
- 2001-01-18 JP JP2001555812A patent/JP5247963B2/ja not_active Expired - Lifetime
- 2001-01-18 WO PCT/EP2001/000560 patent/WO2001055725A2/en active IP Right Grant
- 2001-01-18 AU AU37319/01A patent/AU777837B2/en not_active Expired
- 2001-01-18 BR BR0107851-8A patent/BR0107851A/pt not_active Application Discontinuation
- 2001-01-18 AT AT01909655T patent/ATE342509T1/de active
- 2001-01-18 DE DE1250600T patent/DE1250600T1/de active Pending
- 2001-01-18 DK DK01909655T patent/DK1250600T3/da active
- 2001-01-18 DE DE60123752T patent/DE60123752T2/de not_active Expired - Lifetime
- 2001-01-18 ES ES01909655T patent/ES2274869T3/es not_active Expired - Lifetime
- 2001-01-18 CA CA2397991A patent/CA2397991C/en not_active Expired - Lifetime
- 2001-01-18 EP EP01909655A patent/EP1250600B1/en not_active Expired - Lifetime
- 2001-01-24 US US09/769,180 patent/US6680173B2/en not_active Expired - Lifetime
-
2002
- 2002-11-15 HK HK02108310.4A patent/HK1048513B/zh not_active IP Right Cessation
-
2003
- 2003-10-09 US US10/682,103 patent/US7387879B2/en not_active Expired - Lifetime
-
2007
- 2007-01-11 CY CY20071100047T patent/CY1107993T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1250600A2 (en) | 2002-10-23 |
HK1048513B (zh) | 2007-12-07 |
ATE342509T1 (de) | 2006-11-15 |
ES2274869T3 (es) | 2007-06-01 |
CA2397991C (en) | 2017-10-24 |
JP5247963B2 (ja) | 2013-07-24 |
JP2003521499A (ja) | 2003-07-15 |
US7387879B2 (en) | 2008-06-17 |
EP1250600B1 (en) | 2006-10-11 |
CA2397991A1 (en) | 2001-08-02 |
HK1048513A1 (en) | 2003-04-04 |
DE60123752D1 (de) | 2006-11-23 |
AU3731901A (en) | 2001-08-07 |
US6680173B2 (en) | 2004-01-20 |
BR0107851A (pt) | 2002-10-29 |
AU777837B2 (en) | 2004-11-04 |
DE1250600T1 (de) | 2003-03-06 |
US20030194742A1 (en) | 2003-10-16 |
US20040091942A1 (en) | 2004-05-13 |
WO2001055725A2 (en) | 2001-08-02 |
WO2001055725A3 (en) | 2001-12-20 |
CY1107993T1 (el) | 2013-09-04 |
DE60123752T2 (de) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1250600T3 (da) | Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet | |
ITTO20010411A0 (it) | Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti. | |
HK1041920A1 (en) | Measurement and use of molecular interactions. | |
BR9710836A (pt) | Ensaio de analitos usando marcas em partìculas | |
EE200000486A (et) | Fosfolipaasensüümide inhibiitorid, neid sisaldav farmatseutiline kompositsioon ning meetod põletikulise reaktsiooni raviks imetajal | |
WO2002046746A3 (en) | Method for detection of vitamin d metabolites | |
WO2002027326A3 (en) | Method and kit for the transderaml determination of analyte concentration in blood | |
WO2005052542A3 (en) | Method and composition useful for determining fk 506 | |
BR0101032B1 (pt) | trava e prendedor do ajustador de mancal diferencial de uma peÇa. | |
WO2003016527A3 (en) | Process for the detection of oxidative stress and kit for its implementation | |
WO2001032876A3 (en) | Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions | |
WO2002008461A3 (en) | A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS | |
IL126826A0 (en) | Optical hygrometers | |
WO2004094675A3 (en) | Compositions and methods for determining the presence of sars coronavirus in a sample | |
MXPA03003682A (es) | Metodo para determinar la coagulabilidad y el potencial hemostatico globales. | |
DK0539435T3 (da) | Fremgangsmåde til nedsættelse af interferenser ved en bestemmelse ved fluorescens | |
NO20015157L (no) | Fremgangsmåte ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr | |
WO2001086285A3 (de) | Direkter nachweis von einzelmolekülen | |
BR0014626A (pt) | Análise de leptina | |
WO2002059600A3 (en) | Analyte detection | |
BR0108042A (pt) | Membranas de limitação de difusão de analito fundido usando monÈmeros hidrófilos fotopolimerizáveis | |
WO2005037231A3 (en) | Methods of detecting and treating facioscapulohumeral muscular dystrophy | |
WO2002050543A3 (en) | Free analyte detection system | |
CY1106705T1 (el) | Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου | |
DE69912453D1 (de) | Verfahren und materialien zur diagnose instabiler angina |